Interestingly, the reduction in PU1 and CEBPa levels caused by aberrant ubiquitination signals have been recently described in AML, further demonstrating the importance of a proper TF protein dosage [125,126]. This evidence concerns the gene CEBPA and acute myeloid leukemia.